Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Prelude Therapeutics (PRLD) Return on Assets (2024 - 2025)

Prelude Therapeutics (PRLD) has disclosed Return on Assets for 2 consecutive years, with 0.89% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 14.0% to 0.89% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.89% through Dec 2025, down 14.0% year-over-year, with the annual reading at 0.66% for FY2025, N/A changed from the prior year.
  • Return on Assets hit 0.89% in Q4 2025 for Prelude Therapeutics, up from 1.15% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.75% in Q4 2024 to a low of 1.15% in Q3 2025.